ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Hopkins Investigator Dies In Fall From Denver Hotel Window

May 27, 1977

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991

In Brief: NCI’s First “Zero Based” Budget request Asks For $1.036 Billion; Grants Get Extra $1 Million

September 23, 1977